Some practitioners, such as the PARTNER investigators, are advocating that transcatheter aortic valve implantation (TAVI) become the new standard of care for patients with aortic stenosis who are not suitable surgical candidates. However, others question whether the quality of life, practice management, cost effectiveness and ethical considerations of treating such sick patients have been answered definitively before it becomes routine clinical practice in the U.S.